ARTICLE | Product Development
ACTIV PPP to deliver more COVID therapy data in 2022
The ACTIV adaptive master protocols are testing a range of COVID-19 therapeutic candidates
January 7, 2022 4:45 PM UTC
Forged in crisis and assembled at a speed rarely seen in government, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership launched six adaptive master protocols to study a range of potential therapeutics. These trials are arguably more relevant than ever as SARS-CoV-2 proves its staying power.
Membership in ACTIV, which is managed by the Foundation for NIH (FNIH), includes NIH, CDC, FDA, BARDA and the Countermeasures Acceleration Group (formerly known as Operation Warp Speed), as well as 20 biopharma companies, the Bill & Melinda Gates Foundation and other non-profits. ...